Atreca, Inc. Rings the Closing Bell

ABOUT THIS EVENT

Atreca, Inc. (Nasdaq: BCEL), a biotechnology company focused on developing novel therapeutics based on a deep understanding of the human immune response, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, John Orwin, President & CEO, rang the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore